Previously, a correlation between FAPI uptake and clinical classification of NHL has been demonstrated, with aggressive NHL lesions exhibiting moderate to intense FAP immunostaining and 68Ga-FAPI uptake. The gene discussed is FAP; the disease is non-Hodgkin lymphoma.